Option Care Health, Inc. (NASDAQ:OPCH) Receives Average Recommendation of "Moderate Buy" from Brokerages

Key Points

• Option Care Health, Inc. has received a consensus recommendation of "Moderate Buy" from nine research firms, with an average price target of $35.75.
• JPMorgan Chase & Co. increased its holdings in Option Care Health by 29.6%, reflecting strong institutional interest; 98.05% of the stock is owned by institutional investors and hedge funds.
• In the latest earnings report, Option Care Health reported $0.41 EPS, exceeding analysts' expectations, with a revenue increase of 15.4% compared to the previous year.

Shares of Option Care Health, Inc. (NASDAQ:OPCH - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the nine research firms that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average twelve-month price target among analysts that have covered the stock in the last year is $35.75.

A number of research firms have recently commented on OPCH. JMP Securities set a $38.00 target price on shares of Option Care Health and gave the stock a "market outperform" rating in a research report on Thursday, July 31st. UBS Group upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and lifted their price target for the stock from $38.00 to $40.00 in a research note on Wednesday, April 30th. Citigroup restated an "outperform" rating on shares of Option Care Health in a research note on Thursday, July 31st. Finally, Barrington Research restated an "outperform" rating and issued a $38.00 price target on shares of Option Care Health in a research note on Thursday, July 10th.

Institutional Trading of Option Care Health

Institutional investors and hedge funds have recently modified their holdings of the business. JPMorgan Chase & Co. lifted its position in shares of Option Care Health by 29.6% in the 4th quarter. JPMorgan Chase & Co. now owns 1,511,403 shares of the company's stock worth $35,065,000 after buying an additional 344,875 shares during the last quarter. Compass Wealth Management LLC lifted its position in shares of Option Care Health by 8.9% in the 1st quarter. Compass Wealth Management LLC now owns 166,078 shares of the company's stock worth $5,804,000 after buying an additional 13,600 shares during the last quarter. Bessemer Group Inc. lifted its position in shares of Option Care Health by 62.3% in the 1st quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock worth $54,000 after buying an additional 599 shares during the last quarter. Principal Financial Group Inc. lifted its position in shares of Option Care Health by 1.4% in the 1st quarter. Principal Financial Group Inc. now owns 485,871 shares of the company's stock worth $16,981,000 after buying an additional 6,616 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC lifted its position in shares of Option Care Health by 25.7% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 8,274 shares of the company's stock worth $289,000 after buying an additional 1,691 shares during the last quarter. 98.05% of the stock is owned by institutional investors and hedge funds.

Option Care Health Trading Down 0.6%

NASDAQ OPCH opened at $28.10 on Wednesday. The company's fifty day simple moving average is $30.90 and its 200-day simple moving average is $31.97. Option Care Health has a 52 week low of $21.39 and a 52 week high of $35.53. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.81. The stock has a market cap of $4.56 billion, a P/E ratio of 22.48, a PEG ratio of 1.79 and a beta of 0.79.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its earnings results on Wednesday, July 30th. The company reported $0.41 EPS for the quarter, topping analysts' consensus estimates of $0.40 by $0.01. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. The business had revenue of $1.42 billion for the quarter, compared to analysts' expectations of $1.35 billion. During the same period in the previous year, the company posted $0.30 earnings per share. The business's revenue for the quarter was up 15.4% compared to the same quarter last year. Equities research analysts predict that Option Care Health will post 1.22 EPS for the current fiscal year.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.